ESG Report

Overview

The report presents the company's 2025 progress toward lower-carbon inhaler manufacturing, including the first commercial-scale production lines using HFO-1234ze(E). It reports SBTi validation of near- and long-term emissions targets, including a 54.6% absolute Scope 1-2 reduction target by 2033 and a Net Zero ambition for 2050. The report also describes a completed double materiality assessment, detailed Scope 1-3 emissions and resource data, biodiversity work, and strengthened ESG governance. Selected ESG disclosures received KPMG limited assurance.

Document

Report type: Sustainability Report
Class: Dedicated
Scope: Full report
Fiscal year: 2025
Period: 1 January 2025 – 31 December 2025
Language: English
Pages
File size
Restatement: Disclosed

Reporting standards, commitments and assurance details are available with a free account.

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP
Other

Commitments

UN Global Compact
UN Guiding Principles
Science Based Targets initiative

Ratings

GRI level
SBTi status

Materiality

Assessment
Basis
Matrix

Assurance

Provider
Level
Standard
Scope
Statement included
Metrics assured

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services

Overview